In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Foundation Medicine Inc.

Division of Roche
www.foundationmedicine.com

Latest From Foundation Medicine Inc.

EQRx Aims To Upend Industry’s Pricing Model, With Me-Too Drugs

With a $200m series A financing and an illustrious founding team, including Alexis Borisy and Peter Bach, EQRx plans to develop cheap me-too drugs. The start-up could pose a new threat to big pharma.

StartUps and SMEs Pricing Debate

December 2019 Approvals Snapshot: Abbott Earns New Approval For CentriMag Circulatory Support System

December’s new medical device approvals include the FDA approval of Abbott Laboratories’ CentriMag circulatory support system for postcardiotomy patients, MicroVention’s FRED system for wide-necked intracranial aneurysms and an expanded indication for Foundation Medicine’s FoundationOne CDx cancer-drug companion diagnostic.

Approvals Innovation

Partnerships Are Key To Foundation Medicine's Success

Since receiving approval for the first broad-panel diagnostic test as a combination product to detect cancer, Foundation Medicine has ramped up its partnerships with pharmaceutical companies and other stakeholders. The company expects to receive a similar approval for a broad-panel liquid biopsy genomic test in the first half of 2020.

Commercial Approvals

Novartis Ramps Up Digital Transformation With Microsoft AI Deal

New five-year deal shows convergence of big pharma and big tech continues  though both sectors are wary of hype surrounding AI and digital health.

 

Artificial Intelligence Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Services
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Roche
  • Senior Management
  • Troy Cox, Pres. & CEO
    Jason Ryan, CFO
    Vincent A Miller, MD, CMO
    Ritesh (Tesh) Khullar, Chief Commercial Officer
    Melanie Nallicheri, CBO
    Priti Hegde, PhD, CSO
  • Contact Info
  • Foundation Medicine Inc.
    Phone: (617) 418-2200
    150 Second St.
    Cambridge, MA 02141
    USA
UsernamePublicRestriction

Register